CLL-584 Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib + Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Autor: | Kater, Arnon, Hodkinson, Brendan, Moreno, Carol, Munir, Talha, Levin, Mark-David, Niemann, Carsten, Qi, Keqin, Sinet, Pierre, Baeten, Kurt, Caces, Donne Bennett, Srinivasan, Srimathi |
---|---|
Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S329-S329 |
Databáze: | ScienceDirect |
Externí odkaz: |